Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 901 AL 915

Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review

Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC.

JAMA Neurol. 2017 Mar 1;74(3):339-347. doi: 10.1001/jamaneurol.2016.4899.

Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S.

J Clin Psychiatry. 2017 Mar;78(3):e257-e263. doi: 10.4088/JCP.15m10458.

Copper-2 Hypothesis for Causation of the Current Alzheimer's Disease Epidemic Together with Dietary Changes That Enhance the Epidemic

Brewer GJ.

Chem Res Toxicol. 2017 Mar 20;30(3):763-768. doi: 10.1021/acs.chemrestox.6b00373. Epub 2017 Mar 3.

Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?

Venkataraman A, Kalk N, Sewell G, W Ritchie C, Lingford-Hughes A.

Alcohol Alcohol. 2017 Mar 9;52(2):158. doi: 10.1093/alcalc/agw101.

Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients

Blanco-Silvente L, Castells X, Saez M, Barceló MA, Garre-Olmo J, Vilalta-Franch J, Capellà D.

Int J Neuropsychopharmacol. 2017 Jul 1;20(7):519-528. doi: 10.1093/ijnp/pyx012.

Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology

Robinson M, Lee BY, Hane FT.

J Alzheimers Dis. 2017;57(2):317-330. doi: 10.3233/JAD-161149.

Is Periodontal Disease Associated with Alzheimer's Disease? A Systematic Review with Meta-Analysis

Leira Y, Domínguez C, Seoane J, Seoane-Romero J, Pías-Peleteiro JM, Takkouche B, Blanco J, Aldrey JM.

Neuroepidemiology. 2017;48(1-2):21-31. doi: 10.1159/000458411. Epub 2017 Feb 21.

Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial

Campbell NL, Perkins AJ, Gao S, Skaar TC, Li L, Hendrie HC, Fowler N, Callahan CM, Boustani MA.

J Am Geriatr Soc. 2017 Jul;65(7):1497-1504. doi: 10.1111/jgs.14827. Epub 2017 Mar 14.

What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study

Reed C, Happich M, Argimon JM, Haro JM, Wimo A, Bruno G, Dodel R, Jones RW, Vellas B, Belger M.

J Alzheimers Dis. 2017;57(3):797-812. doi: 10.3233/JAD-160449.

Dementia discourse - A rethink?

McInerney F.

Dementia (London). 2017 May;16(4):409-412. doi: 10.1177/1471301217700535. Epub 2017 Mar 30.

TREM2 and the Progression of Alzheimer's Disease

Gao L, Jiang T, Yao X, Yu L, Yang X, Li Y.

Curr Neurovasc Res. 2017;14(2):177-183. doi: 10.2174/1567202614666170404165201.

Prevalence of Frailty in Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-analysis

Kojima G, Liljas A, Iliffe S, Walters K.

Curr Alzheimer Res. 2017;14(12):1256-1263. doi: 10.2174/1567205014666170417104236.

TREM2, Microglia, and Neurodegenerative Diseases

Yeh FL, Hansen DV, Sheng M.

Trends Mol Med. 2017 Jun;23(6):512-533. doi: 10.1016/j.molmed.2017.03.008. Epub 2017 Apr 22.

Cortisol: Mediator of association between Alzheimer's disease and diabetes mellitus?

Notarianni E.

Psychoneuroendocrinology. 2017 Jul;81:129-137. doi: 10.1016/j.psyneuen.2017.04.008. Epub 2017 Apr 23.

Sex Differences in Risk for Alzheimer's Disease Related to Neurotrophin Gene Polymorphisms: The Cache County Memory Study

Matyi J, Tschanz JT, Rattinger GB, Sanders C, Vernon EK, Corcoran C, Kauwe JSK, Buhusi M.

J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1607-1613. doi: 10.1093/gerona/glx092.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias